HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Malignant Neoplasm|Metastatic Malignant Neoplasm in the Brain|Metastatic Malignant Neoplasm in the Leptomeninges|Breast Cancer|HER2-positive Breast Cancer
Interventions: BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)|California Institute for Regenerative Medicine (CIRM)